PDL BioPharma, Inc.

Historical 13F Holders

Symbol
PDLI
CUSIP
69329Y104
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 7 182 k $28.0 k
2024 Q4 7 182 k $28.0 k
2024 Q3 5 182 k $28.0 k
2024 Q2 7 187 k $28.0 k
2024 Q1 7 187 k $28.0 k
2023 Q4 6 187 k $130 k
2023 Q3 6 187 k $130 k
2023 Q2 7 187 k $130 k
2023 Q1 4 186 k $26.5 k
2022 Q4 4 190 k $0
2022 Q3 3 190 k $0
2022 Q2 3 190 k $0
2022 Q1 6 202 k $27.0 k
2021 Q4 5 205 k $0
2021 Q3 8 15.0 M $41.1 M
2021 Q2 8 15.3 M $37.9 M
2021 Q1 11 14.9 M $36.7 M
2020 Q4 35 42.2 M $107 M
2020 Q3 137 98.5 M $311 M
2020 Q2 141 96.0 M $281 M
2020 Q1 138 91.8 M $667 M
2019 Q4 157 100 M $325 M
2019 Q3 145 99.8 M $216 M
2019 Q2 158 107 M $338 M
2019 Q1 162 116 M $439 M
2018 Q4 158 122 M $352 M
2018 Q3 159 127 M $333 M
2018 Q2 169 128 M $300 M
2018 Q1 182 136 M $399 M
2017 Q4 193 142 M $389 M
2017 Q3 191 138 M $467 M
2017 Q2 178 130 M $322 M
2017 Q1 185 138 M $313 M
2016 Q4 205 133 M $281 M
2016 Q3 208 130 M $435 M
2016 Q2 210 126 M $395 M
2016 Q1 207 128 M $425 M
2015 Q4 218 136 M $482 M
2015 Q3 225 139 M $715 M
2015 Q2 215 147 M $946 M
2015 Q1 226 144 M $1.02 B
2014 Q4 237 160 M $1.24 B
2014 Q3 245 152 M $1.14 B
2014 Q2 237 161 M $1.56 B
2014 Q1 246 141 M $1.17 B